Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma
about
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Autologous Tumor Infiltrating ...... ncreatic Ductal Adenocarcinoma
@en
Autologous Tumor Infiltrating ...... ncreatic Ductal Adenocarcinoma
@nl
type
label
Autologous Tumor Infiltrating ...... ncreatic Ductal Adenocarcinoma
@en
Autologous Tumor Infiltrating ...... ncreatic Ductal Adenocarcinoma
@nl
prefLabel
Autologous Tumor Infiltrating ...... ncreatic Ductal Adenocarcinoma
@en
Autologous Tumor Infiltrating ...... ncreatic Ductal Adenocarcinoma
@nl
P3098
NCT03610490